Highlights

• Natco Pharma stock rose 3.34%, nearing its 52-week high level.
• The stock delivered 40.12% returns over one year, outperforming benchmark indices.
• Trading volumes remained active with strong liquidity indicators during the session.

Shares of Natco Pharma Limited (NSE:NATCOPHARM) were trading at ₹1,162.30 on May 6, 2026, up 3.32% from the previous close of ₹1,125.00. The stock opened at ₹1,137.00 and touched an intraday high of ₹1,169.70, which also marks its 52-week high. The day’s low stood at ₹1,129.30, indicating sustained upward movement during the session.

Source: TradingView

Return Performance Compared to Benchmark

The stock has delivered consistent outperformance across multiple timeframes. Over the past week, it gained 6.35%, compared to a marginal rise of 0.12% in the NIFTY 500 index.

On a one-month basis, the stock advanced 13.07%, outperforming the benchmark’s 8.05% gain. Year-to-date returns stand at 30.94%, while one-year returns are at 40.12%, both significantly higher than benchmark performance.

Over a three-year period, the stock delivered 91.28% returns compared to 49.88% for the index. However, five-year returns at 23.17% lag behind the benchmark’s 83.17% gain.

Trading Activity and Liquidity Indicators

Trading activity remained relatively strong, with volumes of 8.58 lakh shares and a traded value of ₹98.93 crore. The stock’s impact cost stood at 0.03, indicating high liquidity and efficient price discovery.

The deliverable quantity as a percentage of traded volume was 45.03%, reflecting a balanced mix of trading and delivery-based participation.

Market Capitalisation and Volatility

Natco Pharma has a total market capitalisation of ₹20,823.31 crore, with a free float market cap of ₹10,402.99 crore.

The stock recorded daily volatility of 2.37% and annualised volatility of 45.28%. The applicable margin rate stands at 18.78%.

52-Week Range and Technical Levels

The stock reached its 52-week high of ₹1,169.70 during the session, while the 52-week low stands at ₹775.00, recorded on May 9, 2025.

The price band is set at 20%, with an upper band of ₹1,350.00 and a lower band of ₹900.00, defining the permissible trading range.

Key Risks

• Regulatory changes in pharmaceuticals may impact product approvals and revenues.
• Dependence on key products could affect earnings concentration risk.
• Pricing pressures in global generics markets may influence margins.
• Currency fluctuations may impact export-driven revenue streams.

Summary

Natco Pharma (NSE:NATCOPHARM) shares rose 3.34% to ₹1,162.60, nearing their 52-week high during the session. The stock has delivered strong returns across one-month, year-to-date, and one-year periods, outperforming benchmark indices. Trading activity remained high with strong liquidity indicators. Despite positive momentum, long-term performance over five years trails broader market benchmarks.

FAQs

Q: Why did Natco Pharma stock rise today?
A: The stock gained over 3% and approached its 52-week high amid continued positive price momentum.

Q: How has Natco Pharma performed over the past year?
A: The stock delivered 40.12% returns over one year, outperforming the broader market indices.

Q: What is the stock’s 52-week range?
A: The 52-week high is ₹1,169.70, while the 52-week low is ₹775.00.